Transcript Intelligence: Autolus Therapeutics at William Blair Growth Stock Conference
Transcript Intelligence : Autolus Therapeutics à la conférence William Blair Growth Stock
FDA issues draft guidance to help accelerate cell and gene therapies for patients - fda.gov
Autolus Therapeutics to present clinical data update at ASCO annual meeting 2026 ($1.65, 0.00)
Transcript Intelligence: Autolus Therapeutics Q1 Earnings Guidance ($1.50, -0.22)
Transcript Intelligence: Autolus Therapeutics Q1 Earnings Themes ($1.49, -0.22)
Transcript Intelligence: Autolus Therapeutics Q1 Earnings Q&A ($1.50, -0.21)
Autolus Therapeutics reports Q1 EPS ($0.27) vs FactSet ($0.25) [8 est, ($0.30)-(0.21)] ($1.71, 0.00)
Powered by FactSet Research Systems Inc.